TNF and melanoma: An et al. reported that CDG-loaded MSNPs improved the percentages of TNF-α positive CD8+ T cells and IFN-γ positive CD8+ T cells compared to those treated with free CDG, leading to the inhibition of tumor growth in a murine melanoma model [81].